Clinical Trial Platform Uncovers Hidden Signals and Optimizes Next Steps for More Adaptive, Successful, and Efficient Clinical Trials
PhaseV, a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has…
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
The following is a guest article by Rodman Ramezanian, Global Cloud Threat Lead at Skyhigh Security
Healthcare, like other sectors, is undergoing a massive digital transformation to meet the changing needs of patients and workers….
What You Should Know: PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in funding, led by Viola Ventures and…
Continue Reading
We aimed to determine if a novel digital therapeutic intervention could reduce agitation and unscheduled medication use in an adult delirious acute care population. Delirious participants were randomly allocated (1:1) to receive standard of…
Continue Reading
What You Should Know:
– Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
– Through this…
Continue Reading
Sibel Health, a spin-out of Northwestern University, announced the release of its physiological monitoring platform for clinical trial use dubbed Discovery alongside a partnership with AI-powered clinical trial solutions company Medidata. The Illinois-based healthcare technology…
Continue Reading
Background: Percutaneous endoscopic gastrostomy (PEG) is commonly chosen for long-term enteral nutrition support. However, common complications of PEG include wound infection, leakage, obstruction, bleeding, dislodgement, pneumonia, peritonitis, and more. The anticipation of these complications…
Continue Reading
Radionetics Oncology has initiated a Phase 1 clinical trial for 68Ga-R8760, a pioneering radioligand imaging agent designed to detect adrenocortical carcinoma. The study, R8760-101 (NCT05999292), focuses on assessing the agent’s safety and dosimetry. Dr….
Continue Reading
Harman announced this week that it has developed a private large language model trained on a variety of healthcare data sets.WHY IT MATTERSThe Samsung Electronics subsidiary’s advanced deployment techniques using quantization to reduce model…
Continue Reading
